MedPath

Ventilation Inflammation Perfusion and Structure in pediatric Bronchopulmonary Dysplasia Erasmus

Completed
Conditions
10028971
underdeveloped lungs
Bronchopulmonary dysplasia
Registration Number
NL-OMON49241
Lead Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

Patients: diagnosis of BPD according to NHI criteria, age between 6 and 16
years, (in half of the BPD patients,n<=6) routine clinical CT scan planned in
the next six months or received a clinically ordered spirometry controlled CT
in the past six months, informed consent by parents/patient, Premature- non BPD
volunteers: age between 6 and 16 years, born <32 weeks of gestation, informed
consent by parents/patient, Healthy volunteers: age between 6 and 16 years,
informed consent by parents/patient

Exclusion Criteria

Patients: contra- indications for MRI, inability to follow instructions in the
MRI, current severe lung infection (respiratory distress, severe coughing,
antibiotic use for lung infection), chronic oxygen need, Premature non- BPD
patients: contra- indications for MRI, inability to follow instructions in the
MRI, current severe lung infection (respiratory distress, severe coughing,
antibiotic use for lung infection), chronic oxygen need, diagnosis of BPD,
Healthy volunteers: contra- indications for MRI, inability to follow
instructions in the MRI, current severe lung infection (respiratory distress,
severe coughing, antibiotic use for lung infection), chronic oxygen need, born
at a gestational age of less than 37 weeks, presence of pulmonary comorbidities
(asthma, cystic fibrosis, interstitial lung disease etc.)

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The main endpoint of this study is the ability of the MRI protocol to detect<br /><br>structural lung changes related to BPD as established using the VIBE- scoring<br /><br>system, evaluating normal lung tissue, low intensity regions, ventilation<br /><br>defects, presence of airway wall thickening, consolidations and severity of<br /><br>architectural distortion.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>A technical qualitative assessment of the MRIs will be done. The MRI findings<br /><br>will be correlated to spirometry data, MBW measurements and compared to the CT<br /><br>findings.</p><br>
© Copyright 2025. All Rights Reserved by MedPath